查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
血液診斷市場：按產品類型、測試類型和最終用戶分類：2023-2032 年全球機會分析和產業預測
市場調查報告書
商品編碼
1414810

血液診斷市場：按產品類型、測試類型和最終用戶分類：2023-2032 年全球機會分析和產業預測

Hematology Diagnostics Market By Product Type, By Test Type (Complete Blood Count, Platelet Function Testing, Hemoglobin Testing, Others), By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 272 Pages | 商品交期: 2-3個工作天內

價格

由於醫療設備和耗材產業的市場需求不斷增加，2023年至2032年血液診斷市場可能會出現4.4%的顯著成長率。

血液診斷市場-IMG1

血液由多種成分組成，包括血漿（約佔體積的 55%）、紅血球、白血球和血小板（合計約佔體積的 45%）。所有血液中約45%是由紅血球組成，通常稱為紅血球或紅血球，它們將氧氣從肺部輸送到身體組織。白血球也在骨髓中產生，稱為白血球或WBC。白血球和血小板僅佔血液總量的不到 1%。它用於診斷與這些細胞相關的疾病，例如：

1血液系統骨髓惡性腫瘤、凝血障礙、貧血、血紅素異常等均包含在血液診斷中。在血液診斷過程中，需要使用各種儀器和耗材進行血液採樣和篩檢。

最常進行的血液學檢查是全血球計數 (CBC)。此測試通常作為常規檢查的一部分進行，可識別感染疾病、免疫系統疾病、骨髓惡性腫瘤、貧血和凝血障礙。 CBC血液學檢查包括血小板計數、血球比容紅血球品質（HCT）、血紅素濃度（HB）、白血球分類計數、紅血球指數和紅血球計數（RBC）。

推動血液診斷市場成長的主要因素是血液疾病發生率的上升、需要定期血液學檢查的慢性病盛行率的增加以及公眾對定期健康檢查的認知的提高，其中包括意識的提高。隨著血液疾病的增加，血液診斷的需求也越來越大。疑似或確診患有血液疾病的患者需要定期檢測和監測，以做出診斷、評估問題的嚴重性並監測其進展。這正在推動血液診斷市場的發展。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 慢性病增加
      • 提高健康意識和篩檢計劃
      • 快速採用現場護理測試
    • 抑制因素
      • 主要企業產品召回
      • 欠低度開發國家缺乏技能人才
    • 機會
      • 血液診斷技術進步

第4章血液診斷市場：依產品類型

  • 概述
  • 血液檢測設備
    • 血液檢測設備、血液診斷市場：依類型
      • 血液分析設備、血液診斷設備市場（按類型）
      • 按類型分類的流式細胞技術血液診斷設備市場
  • 血液診斷耗材

第5章血液診斷市場：依測試類型

  • 概述
  • 全血球計數 (CBC)
  • 血小板功能檢查
  • 血紅素測試
  • 其他

第6章血液診斷市場：依最終用戶分類

  • 概述
  • 醫院和診所
  • 診斷實驗室
  • 其他

第7章血液診斷市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第8章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第9章 公司簡介

  • Cardinal Health Inc.
  • Danaher Corporation
  • Siemens AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Sysmex Corporation
  • Abbott Laboratories
  • EKF Diagnostics Holdings plc
  • Nihon Kohden Corporation
  • Erba Mannheim
Product Code: A10991

The hematology diagnostic market is likely to experience a significant growth rate of 4.4% from 2023-2032 owing to increasing market demand from medical device & supplies sector - Allied Market Research

Hematology Diagnostics Market - IMG1

Blood is composed of multiple components, including plasma (which makes up approximately 55% of the volume) and red, white, and platelet cells (which together make up approximately 45% of the volume). About 45% of entire blood is composed of red blood cells, usually referred to as erythrocytes or RBCs, transport oxygen from the lungs to the body's tissue. White blood cells, also produced in the bone marrow and referred to as leukocytes or WBCs, aid in the fight against infection. They comprise less than 1% of whole blood, together with platelets. Diagnosis of diseases related to these cells such as hematologic malignancies, coagulopathy, anemia, and hemoglobinopathy are considered under hematology diagnostics. Various instruments and consumables are used in the process of hematology diagnosis for blood collections and screening.

The most commonly performed hematology test is the complete blood count, or CBC. This test is frequently performed as part of a routine examination, and can identify infections, immune system diseases, blood malignancies, anemia, and clotting issues. CBC hematology test includes platelet count, hematocrit red blood cell volume (HCT), hemoglobin concentration (HB), differential white blood count, red blood cell indices and red blood cell count (RBC).

Major factors driving the growth of hematology diagnostics market include rising incidences of blood disorders, rising prevalence of chronic diseases requiring regular hematological testing, and rising awareness among population regarding routine physical checkups. The need for hematology diagnostics is growing as the incidences of blood disorders increase. It is necessary to carry out routine testing and monitoring on patients with suspected or confirmed blood disorders in order to make a diagnosis, assess the severity of the problem, and monitor its course. This is driving the market for hematology diagnostics.

In addition, effective treatment and management of blood diseases depend on early diagnosis and detection of the condition. The significance of early diagnosis has become more widely recognized because of the increased incidences of these illnesses. Hematology test recommendations and execution are mostly recommended by the healthcare professionals, which is fueling the market's expansion.

The market for hematology diagnostics is segmented on the basis of product type, test type, end user, and region. On the basis of product type, the market is segmented into hematology instrument and hematology consumables. The hematology instrument segment is further segmented into hematology analyzers, flow cytometers and others. The hematology analyzers segment is further segmented into fully automated hematology analyzers and semi-automated hematology analyzers, whereas flow cytometry segment is further segmented into cell-based flow cytometry and bead-based flow cytometry. On the basis of test type, the market is segmented into complete blood count (CBC), platelet function test, hemoglobin test and others. Based on end user, the market is segmented into Hospitals & clinics, diagnostic laboratories, and others.

By region, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA. Major players profiled in this report are Cardinal Health Inc., Danaher Corporation, Siemens AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., F. Hoffmann-La Roche Ltd., Sysmex Corporation, Abbott Laboratories, EKF Diagnostics Holdings plc, Nihon Kohden Corporation, and Erba Group.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hematology diagnostics market analysis from 2022 to 2032 to identify the prevailing hematology diagnostics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the hematology diagnostics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global hematology diagnostics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Product Type

  • Hematology Instrument
    • Type
    • Hematology Analyzers

Type

    • Flow Cytometry

Type

    • Others
  • Hematology Consumables

By Test Type

  • Complete Blood Count (CBC)
  • Platelet Function Testing
  • Hemoglobin Testing
  • Others

By End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Cardinal Health Inc.
    • Siemens AG
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • EKF Diagnostics Holdings plc
    • Danaher Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Sysmex Corporation
    • Nihon Kohden Corporation
    • Erba Mannheim

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Growth in prevalence of chronic conditions
      • 3.4.1.2. Growth in awareness of health and screening programs
      • 3.4.1.3. Surge in adoption of point of care testing
    • 3.4.2. Restraints
      • 3.4.2.1. Product recalls by top players
      • 3.4.2.2. Lack of skilled personnel in underdeveloped countries
    • 3.4.3. Opportunities
      • 3.4.3.1. Technological advancements in hematological diagnostics instruments

CHAPTER 4: HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Hematology Instrument
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Hematology Instrument Hematology Diagnostics Market by Type
      • 4.2.4.1. Hematology Analyzers Hematology Diagnostics Market by Type
      • 4.2.4.2. Flow Cytometry Hematology Diagnostics Market by Type
  • 4.3. Hematology Consumables
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Complete Blood Count (CBC)
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Platelet Function Testing
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Hemoglobin Testing
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: HEMATOLOGY DIAGNOSTICS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals and Clinics
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Diagnostic Laboratories
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: HEMATOLOGY DIAGNOSTICS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product Type
    • 7.2.3. Market size and forecast, by Test Type
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product Type
      • 7.2.5.1.2. Market size and forecast, by Test Type
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product Type
      • 7.2.5.2.2. Market size and forecast, by Test Type
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product Type
      • 7.2.5.3.2. Market size and forecast, by Test Type
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product Type
    • 7.3.3. Market size and forecast, by Test Type
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product Type
      • 7.3.5.1.2. Market size and forecast, by Test Type
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Product Type
      • 7.3.5.2.2. Market size and forecast, by Test Type
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Product Type
      • 7.3.5.3.2. Market size and forecast, by Test Type
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Product Type
      • 7.3.5.4.2. Market size and forecast, by Test Type
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Product Type
      • 7.3.5.5.2. Market size and forecast, by Test Type
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product Type
      • 7.3.5.6.2. Market size and forecast, by Test Type
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product Type
    • 7.4.3. Market size and forecast, by Test Type
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Product Type
      • 7.4.5.1.2. Market size and forecast, by Test Type
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Product Type
      • 7.4.5.2.2. Market size and forecast, by Test Type
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product Type
      • 7.4.5.3.2. Market size and forecast, by Test Type
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Product Type
      • 7.4.5.4.2. Market size and forecast, by Test Type
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Product Type
      • 7.4.5.5.2. Market size and forecast, by Test Type
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product Type
      • 7.4.5.6.2. Market size and forecast, by Test Type
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product Type
    • 7.5.3. Market size and forecast, by Test Type
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product Type
      • 7.5.5.1.2. Market size and forecast, by Test Type
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Product Type
      • 7.5.5.2.2. Market size and forecast, by Test Type
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Product Type
      • 7.5.5.3.2. Market size and forecast, by Test Type
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Product Type
      • 7.5.5.4.2. Market size and forecast, by Test Type
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Cardinal Health Inc.
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Danaher Corporation
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Siemens AG
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. F. Hoffmann-La Roche Ltd.
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Sysmex Corporation
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. Abbott Laboratories
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
    • 9.7.7. Key strategic moves and developments
  • 9.8. EKF Diagnostics Holdings plc
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. Nihon Kohden Corporation
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. Erba Mannheim
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 02. HEMATOLOGY DIAGNOSTICS MARKET FOR HEMATOLOGY INSTRUMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. GLOBAL HEMATOLOGY INSTRUMENT HEMATOLOGY DIAGNOSTICS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL HEMATOLOGY ANALYZERS HEMATOLOGY DIAGNOSTICS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL FLOW CYTOMETRY HEMATOLOGY DIAGNOSTICS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 06. HEMATOLOGY DIAGNOSTICS MARKET FOR HEMATOLOGY CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 08. HEMATOLOGY DIAGNOSTICS MARKET FOR COMPLETE BLOOD COUNT (CBC), BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. HEMATOLOGY DIAGNOSTICS MARKET FOR PLATELET FUNCTION TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. HEMATOLOGY DIAGNOSTICS MARKET FOR HEMOGLOBIN TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. HEMATOLOGY DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 13. HEMATOLOGY DIAGNOSTICS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. HEMATOLOGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. HEMATOLOGY DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. HEMATOLOGY DIAGNOSTICS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. U.S. HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. U.S. HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 23. U.S. HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. CANADA HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 25. CANADA HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 26. CANADA HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE HEMATOLOGY DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. UK HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. UK HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 42. UK HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. ITALY HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 44. ITALY HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 45. ITALY HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 48. SPAIN HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. CHINA HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. CHINA HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 61. CHINA HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. INDIA HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 63. INDIA HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 64. INDIA HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 73. REST OF ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 75. LAMEA HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 76. LAMEA HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. LAMEA HEMATOLOGY DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 78. BRAZIL HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 79. BRAZIL HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 80. BRAZIL HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. SAUDI ARABIA HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 82. SAUDI ARABIA HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 83. SAUDI ARABIA HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH AFRICA HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH AFRICA HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH AFRICA HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. REST OF LAMEA HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 88. REST OF LAMEA HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 89. REST OF LAMEA HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. CARDINAL HEALTH INC.: KEY EXECUTIVES
  • TABLE 91. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
  • TABLE 92. CARDINAL HEALTH INC.: PRODUCT SEGMENTS
  • TABLE 93. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
  • TABLE 94. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 95. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 96. DANAHER CORPORATION: PRODUCT SEGMENTS
  • TABLE 97. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 98. SIEMENS AG: KEY EXECUTIVES
  • TABLE 99. SIEMENS AG: COMPANY SNAPSHOT
  • TABLE 100. SIEMENS AG: PRODUCT SEGMENTS
  • TABLE 101. SIEMENS AG: PRODUCT PORTFOLIO
  • TABLE 102. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: KEY EXECUTIVES
  • TABLE 103. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT
  • TABLE 104. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT SEGMENTS
  • TABLE 105. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 106. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
  • TABLE 107. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 108. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
  • TABLE 109. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 110. F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES
  • TABLE 111. SYSMEX CORPORATION: KEY EXECUTIVES
  • TABLE 112. SYSMEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 113. SYSMEX CORPORATION: PRODUCT SEGMENTS
  • TABLE 114. SYSMEX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 115. SYSMEX CORPORATION: KEY STRATERGIES
  • TABLE 116. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 117. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 118. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 119. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 120. ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 121. EKF DIAGNOSTICS HOLDINGS PLC: KEY EXECUTIVES
  • TABLE 122. EKF DIAGNOSTICS HOLDINGS PLC: COMPANY SNAPSHOT
  • TABLE 123. EKF DIAGNOSTICS HOLDINGS PLC: PRODUCT SEGMENTS
  • TABLE 124. EKF DIAGNOSTICS HOLDINGS PLC: PRODUCT PORTFOLIO
  • TABLE 125. NIHON KOHDEN CORPORATION: KEY EXECUTIVES
  • TABLE 126. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
  • TABLE 127. NIHON KOHDEN CORPORATION: PRODUCT SEGMENTS
  • TABLE 128. NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
  • TABLE 129. ERBA MANNHEIM: KEY EXECUTIVES
  • TABLE 130. ERBA MANNHEIM: COMPANY SNAPSHOT
  • TABLE 131. ERBA MANNHEIM: PRODUCT SEGMENTS
  • TABLE 132. ERBA MANNHEIM: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF HEMATOLOGY DIAGNOSTICS MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN HEMATOLOGY DIAGNOSTICS MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN HEMATOLOGY DIAGNOSTICS MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF HEMATOLOGY DIAGNOSTICS MARKET FOR HEMATOLOGY INSTRUMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF HEMATOLOGY DIAGNOSTICS MARKET FOR HEMATOLOGY CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF HEMATOLOGY DIAGNOSTICS MARKET FOR COMPLETE BLOOD COUNT (CBC), BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF HEMATOLOGY DIAGNOSTICS MARKET FOR PLATELET FUNCTION TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HEMATOLOGY DIAGNOSTICS MARKET FOR HEMOGLOBIN TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HEMATOLOGY DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. HEMATOLOGY DIAGNOSTICS MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF HEMATOLOGY DIAGNOSTICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF HEMATOLOGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF HEMATOLOGY DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. HEMATOLOGY DIAGNOSTICS MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 24. U.S. HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. CANADA HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. MEXICO HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. GERMANY HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. FRANCE HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. UK HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. ITALY HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. SPAIN HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. REST OF EUROPE HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. JAPAN HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. CHINA HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. INDIA HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. AUSTRALIA HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. SOUTH KOREA HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. BRAZIL HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SAUDI ARABIA HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. SOUTH AFRICA HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. REST OF LAMEA HEMATOLOGY DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: HEMATOLOGY DIAGNOSTICS MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2022
  • FIGURE 50. CARDINAL HEALTH INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 51. CARDINAL HEALTH INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 52. CARDINAL HEALTH INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 53. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 55. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. SIEMENS AG: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 57. SIEMENS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 58. SIEMENS AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 59. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 60. F. HOFFMANN-LA ROCHE LTD.: SALES REVENUE, 2020-2022 ($MILLION)
  • FIGURE 61. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 62. SYSMEX CORPORATION: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 63. SYSMEX CORPORATION: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 64. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 65. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 66. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 67. EKF DIAGNOSTICS HOLDINGS PLC: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 68. EKF DIAGNOSTICS HOLDINGS PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 69. NIHON KOHDEN CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 70. NIHON KOHDEN CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 71. NIHON KOHDEN CORPORATION: REVENUE SHARE BY REGION, 2022 (%)